NCT04660591

Brief Summary

Proximal femoral metastatic disease is a common cause of morbidity and mortality in cancer patients.protecting the entire femur using long nail or long femoral stem was hypothesized to prevent future fracture.However we believe that long stem isn't always necessary and won't decrease the complication rate.noting it's increased complication rate in this high risk patient category .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 9, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
Last Updated

July 20, 2021

Status Verified

July 1, 2021

Enrollment Period

1.5 years

First QC Date

November 27, 2020

Last Update Submit

July 19, 2021

Conditions

Keywords

pathological, metastasis ,cement reactionlong stem

Outcome Measures

Primary Outcomes (2)

  • MSTS score

    The Musculoskeletal Tumor Society (MSTS) scoring system is a disease-specific instrument to determine the physical and mental health for patients with extremity sarcoma

    Implant-specific differences in postoperative functional outcomes will be determined and compared throughout the study period at different time points(preoperative, postoperative at one month, six months and one year)

  • survival

    median and mean patient survival

    Implant-specific differences in survival will be determined and compared throughout the study period at different time points(preoperative, postoperative at one month, six months and one year)

Secondary Outcomes (3)

  • visual analogue score

    improvement of pain compared to preoperative status

  • the Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status

    implant specific ECOG as a measure of patient functional level compared at different time points(preoperative ,one month ,six months and one year postoperative)

  • complications

    will be reported during one year follow up

Study Arms (2)

standard femoral stem

ACTIVE COMPARATOR

standard length femoral stem arthroplasty applied for patients with proximal femoral metastasis either impending or pathological fracture

Device: femoral stem in hip arthroplasty

long femoral stem

ACTIVE COMPARATOR

long femoral stem arthroplasty applied for patients with proximal femoral metastasis either impending or pathological fracture

Device: femoral stem in hip arthroplasty

Interventions

using lateral approach to the hip we will compare the effect of femoral stem length on the oncological and functional outcomes in patients with proximal femoral metastasis.hip arthroplasty is a surgical procedure that involves changing the head of the femur (the ball) with or without replacing the articular surface of the acetabulum (the socket ).and replacing it with metal head based on a stem covered with cement to fix it to the bone of the femur.

Also known as: cemented hip arthroplasty , hip replacement
long femoral stemstandard femoral stem

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pathological or impending pathological pertrochanteric or neck femur fracture, regardless of the presence of distal femoral metastasis.

You may not qualify if:

  • Previous arthroplasty in the same side. fractures or lesions involving the subtrochanteric region Pathological fracture due to metabolic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AinShams university

Cairo, Abbasid, Egypt

Location

Related Publications (6)

  • Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s. doi: 10.1158/1078-0432.CCR-06-0931.

    PMID: 17062708BACKGROUND
  • Schneiderbauer MM, von Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am. 2004 Aug;86(8):1684-9. doi: 10.2106/00004623-200408000-00011.

    PMID: 15292415BACKGROUND
  • Tsuda Y, Yasunaga H, Horiguchi H, Fushimi K, Kawano H, Tanaka S. Complications and Postoperative Mortality Rate After Surgery for Pathological Femur Fracture Related to Bone Metastasis: Analysis of a Nationwide Database. Ann Surg Oncol. 2016 Mar;23(3):801-10. doi: 10.1245/s10434-015-4881-9. Epub 2015 Oct 5.

    PMID: 26438441BACKGROUND
  • Xing Z, Moon BS, Satcher RL, Lin PP, Lewis VO. A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases. Clin Orthop Relat Res. 2013 May;471(5):1622-7. doi: 10.1007/s11999-013-2790-4. Epub 2013 Jan 30.

    PMID: 23361930BACKGROUND
  • Peterson JR, Decilveo AP, O'Connor IT, Golub I, Wittig JC. What Are the Functional Results and Complications With Long Stem Hemiarthroplasty in Patients With Metastases to the Proximal Femur? Clin Orthop Relat Res. 2017 Mar;475(3):745-756. doi: 10.1007/s11999-016-4810-7.

  • Abdelmonem IM, Azmy SI, El Masry AM, El Ghazawy AK, Kotb AS, Bassiony AA. Cemented long versus standard femoral stem in proximal femoral metastasis: a noninferiority single-blinded quasi-randomized clinical trial. Eur J Trauma Emerg Surg. 2022 Aug;48(4):2977-2985. doi: 10.1007/s00068-021-01875-x. Epub 2022 Feb 13.

MeSH Terms

Conditions

Bone NeoplasmsFractures, SpontaneousNeoplasm Metastasis

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal DiseasesFractures, BoneWounds and InjuriesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
only participants were blinded from treatment group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two comparative groups, standard and long femoral stem arthroplasty
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

November 27, 2020

First Posted

December 9, 2020

Study Start

November 1, 2019

Primary Completion

May 1, 2021

Study Completion

May 30, 2021

Last Updated

July 20, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
after publishing the study no limit regarding how long data will be shared

Locations